📈
📈 Business
Moderna shares surge 177% after mRNA melanoma vaccine clinical success
Moderna's shares surged nearly 177% in a single trading session on Wall Street after the company announced a clinical success for its mRNA melanoma vaccine. While ordinary shareholders saw their holdings more than double in value, options traders stood to make gains of close to one million percent. It ranks as one of the largest single-day moves in Moderna's listed history.
Comments
No comments yet
Comments
No comments yet — be the first to weigh in 👇
No comments yet. Be the first!